Press Release
|
· Hetero Healthcare Limited announces availability of its Oseltamivir drug FLUVIR for Swine flu in Indian retail market
· Hetero is the only company holding licensing right to manufacture and supply Oseltamivir in India and other 100 countries
· FLUVIR is the first Oseltamivir drug in India to treat H1N1 patient
· Hetero was the first pharma company to supply anti Swine flu drugs to the Govt. of India to address the H1N1 outbreak in India
· Hetero has supplied more than 60% of the total anti Swine flu drugs procured by Govt. of India
Mumbai, 22nd September 2009: Hetero Healthcare Limited, a fast growing Indian drug manufacturer, announces today that it’s anti Swine flu drug - FLUVIR is now available in retail market across India.
Before the Government notification of allowing retail sale of anti-viral drug Oseltamivir, generic name of the anti H1N1 flu drug, Govt. of India procured 19 million FLUVIR capsules from Hetero to check the recent outbreak of deadly H1N1 flu in India . FLUVIR was available only through Govt. hospitals and now will be available in around 480 designated medical shops having Schedule X licence across the country.
Hetero is the only Indian pharma company to have the licensing rights from Hoffmann-La Roche Ltd, to manufacture & supply Oseltamivir in India as well as in other 100 underdeveloped and developing countries. Hetero brings to India FLUVIR with collaboration benefits of expertise and back-up yielding product of international quality. FLUVIR is the first Oseltamivir drug launched in Indian retail market.
Responding to the request of the Govt. of India to increase the production capacity from 100 million capsules per month to 200 million capsules per month, Hetero has come up with dedicated manufacturing facilities in Vishakapatnam exclusively to produce FLUVIR. It is fully prepared with adequate raw materials and manufacturing capacities to meet the demand of FLUVIR to treat millions of Swine flu patients.
Srinivas Reddy, Marketing Director, Hetero said: “We are proud of being the first company to launch this Oseltamivir drug in the Indian retail market and in making the drug available in such huge numbers to address the current outbreak of the H1N1 virus in India. With our manufacturing facilities exclusively for FLUVIR, HETERO will be able to deliver sufficient number of doses to treat more than 2 crore people in an emergency situation”
Availability & Price of FLUVIR:
· FLUVIR is available in an around 480 medical shops having Schedule X license.
· Two copies of prescription of the drug have to be produced to purchase FLUVIR
· While selling this drug, pharmacists have to make a record of the prescriptions, name of the doctor and the person to whom it was sold.
· Price is Rs. 450 for 10 capsules- 1 therapy
About Hetero Healthcare Limited:
Hetero visualizes itself as an aggressive player in the global pharmaceutical scenario, supplying generics developed, combining intellectual property, research strengths and strong human resource inputs.
With six manufacturing facilities being supported by excellent infrastructure and compliance to the GMP requirements, Hetero Healthcare manufactures and markets its products in over 100 countries in Asia , Middle-east, Eastern Europe , Latin America , United States , Canada and Europe .
Hetero received National Award for Best Efforts in Research and Development from the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India, in the year 1996 and Highest Exporter award for the year 1999.
For further details, contact:
D. Roy
Email: droy@deeshapr.com
Tel: +91-6579 4981
Rajesh Usgaokar
DGM, Marketing
Hetero Healthcare Ltd.